Global Cardiac POC Market 2014-2018
出 版 商：Technavio
出版日期：2014/08/06
頁 數：63頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 2,800 (Multi-User License)
USD 3,500 (Global-User License)
USD 2,800 (Multi-User License)
USD 3,500 (Global-User License)
About Cardiac POC
Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides. The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients.
TechNavio's analysts forecast the Global Cardiac POC market will grow at a CAGR of 14.40 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT.
The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC market. In addition, it discusses the major drivers that influence the growth of the Global Cardiac POC market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
TechNavio's report, the Global Cardiac POC Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cardiac POC market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ EMEA
‧ APAC
Key Vendors
‧ Alere Inc.
‧ Abbott Laboratories
‧ Roche Diagnostics
Other Prominent Vendors
‧ Beckman Coulter, Inc.
‧ BG Medicine Inc.
‧ Boston Scientific Corp
‧ Medtronic Inc.
‧ Randox Laboratories Ltd.
Key Market Driver
‧ Increasing Incidence of Cardiac Disorders.
‧ For a full, detailed list, view our report.
Key Market Challenge
‧ Lack of Specific Actions in Detecting the Presence of Cardiovascular Diseases.
‧ For a full, detailed list, view our report.
Key Market Trend
‧ Introduction of Enhanced Products.
‧ For a full, detailed list, view our report.
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides. The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients.
TechNavio's analysts forecast the Global Cardiac POC market will grow at a CAGR of 14.40 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT.
The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC market. In addition, it discusses the major drivers that influence the growth of the Global Cardiac POC market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
TechNavio's report, the Global Cardiac POC Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cardiac POC market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ EMEA
‧ APAC
Key Vendors
‧ Alere Inc.
‧ Abbott Laboratories
‧ Roche Diagnostics
Other Prominent Vendors
‧ Beckman Coulter, Inc.
‧ BG Medicine Inc.
‧ Boston Scientific Corp
‧ Medtronic Inc.
‧ Randox Laboratories Ltd.
Key Market Driver
‧ Increasing Incidence of Cardiac Disorders.
‧ For a full, detailed list, view our report.
Key Market Challenge
‧ Lack of Specific Actions in Detecting the Presence of Cardiovascular Diseases.
‧ For a full, detailed list, view our report.
Key Market Trend
‧ Introduction of Enhanced Products.
‧ For a full, detailed list, view our report.
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Tests
08. Global Cardiac Troponin Test Market
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Cardiac BNP Test Market
09.1 Market Overview
09.2 Market Size and Forecast
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2012
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Business Strategy
19.1.7 Key Developments
19.1.8 SWOT Analysis
19.1.9 Strengths
19.1.10 Weakness
19.1.11 Opportunities
19.1.12 Threats
19.2 Alere
19.2.1 Business Overview
19.2.2 Business Segmentation
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Geographical Segmentation by Revenue 2013
19.2.5 Business Strategy
19.2.6 Recent Developments
19.2.7 SWOT Analysis
19.2.8 Strengths
19.2.9 Weaknesses
19.2.10 Opportunities
19.2.11 Threats
19.3 Roche Diagnostics
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Geographical Segmentation by Revenue 2013
19.3.5 Business Strategy
19.3.6 Recent Developments
19.3.7 SWOT Analysis
19.3.8 Strengths
19.3.9 Weaknesses
19.3.10 Opportunities
19.3.11 Threats
19.3.12 Other Reports in Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Cardiac POC Market for 2013-2018 in (US$ million)
Exhibit 3: Global Cardiac POC Market Segmentation by Type of Test
Exhibit 4: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018 in (US$ million)
Exhibit 5: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018
Exhibit 6: Global Cardiac Troponin Test Market 2013-2018 (US$ million)
Exhibit 7: Global Cardiac BNP Test Market 2013-2018 (US$ million)
Exhibit 8: Global Cardiac POC Market by Geographical Segmentation 2013
Exhibit 9: Global Cardiac POC Market Vendor Share Analysis 2013
Exhibit 10: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 11: Abbott Laboratories: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 12: Abbott Laboratories: Sales by Geography 2012
Exhibit 13: Business Segmentation of Alere
Exhibit 14: Alere Business Segmentation by Revenue 2013
Exhibit 15: Alere Geographical Segmentation by Revenue 2013
Exhibit 16: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 17: Roche Diagnostics: Geographical Segmentation by Revenue 2013
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Tests
08. Global Cardiac Troponin Test Market
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Cardiac BNP Test Market
09.1 Market Overview
09.2 Market Size and Forecast
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2012
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Business Strategy
19.1.7 Key Developments
19.1.8 SWOT Analysis
19.1.9 Strengths
19.1.10 Weakness
19.1.11 Opportunities
19.1.12 Threats
19.2 Alere
19.2.1 Business Overview
19.2.2 Business Segmentation
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Geographical Segmentation by Revenue 2013
19.2.5 Business Strategy
19.2.6 Recent Developments
19.2.7 SWOT Analysis
19.2.8 Strengths
19.2.9 Weaknesses
19.2.10 Opportunities
19.2.11 Threats
19.3 Roche Diagnostics
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Geographical Segmentation by Revenue 2013
19.3.5 Business Strategy
19.3.6 Recent Developments
19.3.7 SWOT Analysis
19.3.8 Strengths
19.3.9 Weaknesses
19.3.10 Opportunities
19.3.11 Threats
19.3.12 Other Reports in Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Cardiac POC Market for 2013-2018 in (US$ million)
Exhibit 3: Global Cardiac POC Market Segmentation by Type of Test
Exhibit 4: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018 in (US$ million)
Exhibit 5: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018
Exhibit 6: Global Cardiac Troponin Test Market 2013-2018 (US$ million)
Exhibit 7: Global Cardiac BNP Test Market 2013-2018 (US$ million)
Exhibit 8: Global Cardiac POC Market by Geographical Segmentation 2013
Exhibit 9: Global Cardiac POC Market Vendor Share Analysis 2013
Exhibit 10: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 11: Abbott Laboratories: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 12: Abbott Laboratories: Sales by Geography 2012
Exhibit 13: Business Segmentation of Alere
Exhibit 14: Alere Business Segmentation by Revenue 2013
Exhibit 15: Alere Geographical Segmentation by Revenue 2013
Exhibit 16: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 17: Roche Diagnostics: Geographical Segmentation by Revenue 2013
